Provision of Oncotype DX Breast Recurrence ScoreTM Assay

GoodsAward procedure without prior publication of a call for competition

Awarded value£450,000published contract · exc. VAT

Awarded 26 Jun 2023no call for competition

Awarded to Exact Sciences UK, Ltd.2 awards

What is being bought

Published requirement description

Procurement of the Provision of Oncotype DX Breast Recurrence ScoreTM Assay

CPV: Medical equipments, pharmaceuticals and personal care products

single lot · no lot value published

Lot #1The procurement for the Provision of Oncotype DX Breast Recurrence ScoreTM AssayAwarded

Delivery: Northern Ireland · Belfast Health and Social Care Trust Laboratories

From the official record

Procedure method: Award procedure without prior publication of a call for competition
Legal basis: CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category: Goods
Notice status: Awarded without competition
Procurement threshold: Unspecified in notice
Regulatory regime: Standard
Commercial structure: Stand-alone contract (no framework)
Competition type: Direct award (no call for competition)
GPA / WTO covered: Yes (GPA)
Recurring procurement: Unspecified in notice
First published: 9 Jun 2023, 12:15 BST
Last source update: 28 Jun 2023, 10:42 BST
Authority reference: DAC11239
FTS notice number: 2023/S 000-018358
Classification (CPV): Medical equipments, pharmaceuticals and personal care products
Delivery area: Northern Ireland (UKN)
Official registry OCID: ocds-h6vhtk-03d509 Find a Tender

Why no open competition: The works, supplies or services can be provided only by a particular economic operator due to absence of competition for technical reasons
Published justification: No reasonable alternative exists for this procurement Provision of Oncotype DX Breast Recurrence Score Assay is available from only one economic operator and is essential for service delivery and patient care for breast cancer patients in Northern Ireland, the absence of competition is not the result of an artificial narrowing down of the parameters of this procurement.

Published awards, contracts and bid statistics, not a forecast

Awards 2

Awarded value £450,0001 contract exc. VAT · 1 repeated publication of the same award counted once

Bids received 1

Contracts signed 2latest 26 Jun 2023

Awarded to	Value	Date	Status
Exact Sciences UK, Ltd.	£450,000 †same award published again · counted once	—	Awarded
Exact Sciences UK, Ltd.	£450,000 †	—	Awarded

Contracts

Provision of Oncotype DX Breast Recurrence ScoreTM Assay · Exact Sciences UK, Ltd.
Signed
26 Jun 2023
Value
£450,000
Status
active
Provision of Oncotype DX Breast Recurrence ScoreTM Assay · Exact Sciences UK, Ltd.
Signed
9 Jun 2023
Value
£450,000
Status
active

Bid statistics published by the authority

Bids	SME	VCSE	Valid bid range
1bids	—	—	—

Contracting authorityCentral GovernmentBody governed by public lawHealth LISBURN ROAD, BELFAST, Northern Ireland, BT97ABContact name, email

1 commercial party on the notice

Exact Sciences UK LtdAwarded supplierGB-COH: 07484560 100 New Bridge Street, London, London, EC4V 6JA

Official links; attachments are not copied

No document links were published on the notice.